Good
Mostly Aligned
Patient Risk:
Low
Summary
The AI response largely aligns with the label on uses and pediatric restrictions and the explicit 12+ dosing. It correctly notes the 4 tablets/day maximum and that under-12s should not use. It omits critical dosing specifics (mg per dose/day, ER dosing) and cautions regarding combination products and allergy contraindications, which are not fully described in the provided label excerpts.
Category Scores
Accurate Statements
Guaifenesin is used to loosen phlegm/mucus and make coughs more productive.
USE(S)
Adults and children 12 years and older: 1 or 2 tablets every 12 hours; max 4 tablets per 24 hours.
DIRECTIONS
Children under 12 years of age should not use this product.
DO NOT USE
Pregnant or breastfeeding individuals should ask a health professional before use.
IF PREGNANT OR BREAST-FEEDING
Unsupported Statements
Guaifenesin comes in syrups or single-ingredient formulations.
Not described in label excerpt.
Guaifenesin is often sold in combination cough/cold products (e.g., with dextromethorphan, phenylephrine, acetaminophen, etc.).
No discussion of combination products in the label excerpt.
Immediate-release products: usually 200–400 mg every 4 hours; maximum around 2,000 mg per day (some labels say up to 2,400 mg/day).
mg per dose and per-day mg ranges not provided in excerpt.
Extended-release (ER) products: often 600 mg every 12 hours (about 1,200 mg per day).
ER dosing not provided in excerpt.
Not recommended if you’re allergic to guaifenesin.
Allergy contraindication not shown in provided Do Not Use section.
Guaifenesin can cause mild side effects like upset stomach, dizziness, or drowsiness.
No adverse events listed in provided sections.
If you have chronic cough, asthma/COPD, or you’re pregnant/breastfeeding, check with a healthcare provider before use.
Chronic cough/asthma/COPD not explicitly addressed; only pregnancy/breastfeeding guidance present.
Don’t use multiple products that each contain guaifenesin to avoid exceeding the recommended total daily dose.
Explicit multi-product caution not provided; only a daily tablet limit is stated.
Contradictions
Important Omissions
Explicit mg per tablet and per-dose mg guidance; mg/day maximums; ER dosing specifics.
Importance:
High
Allergy contraindication in Do Not Use; explicit adverse reactions/safety profile.
Importance:
High
Combination product cautions and drug interaction guidance.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Mostly aligns with label's limited safety info in excerpt; significant safety details (allergy, adverse events) not present in excerpt.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement
Include explicit mg per dose/day information, ER dosing, allergy contraindications, and cautions on combination products; clarify whether syrups/single-ingredient formulations are within product label scope.